Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
Under what circumstances would you consider LDL apheresis in a kidney transplant patient with FSGS recurrence within three months of transplantation?
Related Questions
Would you order a repeat DEXA scan 1 year later for a kidney transplant patient who had an initial DEXA scan within the first 6 months post-transplant showing osteopenia but no history of fractures, and who has been stable on glucocorticoid-free immunosuppressive therapy?
How do you distinguish TMA caused by CNI toxicity versus antibody mediated rejection in a kidney transplant patient?
What is your approach to management of tremors in a kidney transplant recipient who is taking a CNI for immunosuppression?
How do you approach chronic active AMR concurrent with changes of CNI toxicity?
Do you recommend plasmapheresis prior to kidney transplantation for patients with elevated panel-reactive antibody percentages?
What is your approach to managing a kidney transplant patient who develops BK viremia after treatment for rejection?
How much proteinuria would warrant consideration of native kidney nephrectomies at the time of a kidney transplant?
What is the best way to assess exercise capacity in kidney transplantation candidates to predict post-transplant outcomes?
What is your approach to dose adjusting mycophenolate in a kidney transplant recipient who is transitioned from tacrolimus to cyclosporine?
Do you have specific waiting periods before a patient can be listed for a kidney transplant if they have a past history of malignancy?
